CClinicalTrials.gg
RecruitingNCT06076902Updated Oct 11, 2023

Patch Study (Patch-augmented Rotator Cuff Repair)

An interventional study of Arthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch (Pitch-Patch Tissue Reinforcement Device)) and Arthroscopic rotator cuff reconstruction using fixation with anchors augmented without a synthetic polyester patch in Rotator Cuff Tears, sponsored by Spital Thurgau AG. Recruiting at 1 site in Switzerland. Open to participants aged 30 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-10-11.

Sponsored by Spital Thurgau AG · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2023, registered Sep 2023).
  • Started Apr 2023; still recruiting 3 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
30 Years to 75 Years
Sex
All
01

Study summary

This single-center, prospective, randomized controlled study will compare patients allocated to two treatment arms who are undergoing surgery to repair rotator cuff tears: (1) arthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch, and (2) arthroscopic rotator cuff reconstruction using fixation with anchors and no augmentation with a synthetic polyester patch. The primary objective is to compare complications (primarily retear rates) and the secondary objective is to compare mid- and long-term clinical and radiological outcomes using standard orthopedic assessments, such as the subjective shoulder value and the Constant-Murley score.

Read the detailed description

This single-center, prospective, randomized controlled study will compare patients allocated to two treatment arms who are undergoing surgery to repair rotator cuff tears: (1) arthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch, and (2) arthroscopic rotator cuff reconstruction using fixation with anchors and no augmentation with a synthetic polyester patch. The primary objective is to compare complications (primarily retear rates) and the secondary objective is to compare mid- and long-term clinical and radiological outcomes using standard orthopedic assessments, such as the subjective shoulder value and the Constant-Murley score.

The Pitch-Patch is a single-use synthetic polyester patch (Pitch-Patch, neoligamentsTM, Leeds, UK) intended to reinforce the rotator cuff following or during repair by sutures or suture anchors where weakness exists in the soft tissue. The surgical group will be randomly assigned, and each group will include 150 patients. After surgery, patients will be followed for two years and undergo clinical and radiological assessments.

The main research question to be answered by this investigation is whether synthetic patch augmentation can significantly improve outcomes in patients with rotator cuff tears from either degenerative or traumatic origins versus patients with no patch augmentation.

02

Conditions studied

  • Rotator Cuff Tears

Browse trials for

Keywords

  • Rotator Cuff Repair
03

In context

Rotator Cuff Injuries

734 studies on the registry are indexed under Rotator Cuff Injuries; 161 are open to participants now.

This study's planned enrollment of 300 is above the median of 60 across 538 interventional studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

Spital Thurgau AG is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults with massive rotator cuff tear
  • Tear must affect at least two tendons
  • Primary surgery only
  • Origin of tear can be either degenerative or traumatic
  • German language speaking

Exclusion criteria

Exclusion Criteria:

  • Fatty infiltration grade 4 (according to Goutallier)
  • Bilateral tears
  • Cases of arthritis or severe osteoarthritis
  • Structural or pathological condition of the bone or soft tissue that could impair healing
  • Unable or unwilling to restrict activities to prescribed levels or follow rehabilitation guidelines
  • Unable or unwilling to give consent (language barrier or cognitive impairment)
  • Unwilling or unable to be assessed at 1- and 2-year follow-up assessment visits
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Treatment group with patch augmentation

    Arthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch

    Device: Arthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch (Pitch-Patch Tissue Reinforcement Device))

  • Active comparator
    Comparison group without patch augmentation

    Arthroscopic rotator cuff reconstruction using fixation with anchors and no augmentation with a synthetic polyester patch

    Device: Arthroscopic rotator cuff reconstruction using fixation with anchors augmented without a synthetic polyester patch

Interventions

  • DeviceArthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch (Pitch-Patch Tissue Reinforcement Device))

    The Pitch-Patch is a single-use device intended to reinforce the rotator cuff following or during repair by sutures or suture anchors where weakness exists in the soft tissue.

    Also known as: Pitch-Patch Tissue Reinforcement Device (version model number 102-1090)

  • DeviceArthroscopic rotator cuff reconstruction using fixation with anchors augmented without a synthetic polyester patch

    Arthroscopic rotator cuff reconstruction using fixation with anchors and no augmentation with a synthetic polyester patch.

06

What researchers measure

Primary outcomes

  1. Rotator cuff retear rate

    Occurence of retear following rotator cuff reconstruction to treat massive tear (measured using radiological imaging/ultrasound)

    Time frame: Up to two years postoperative

Secondary outcomes

  1. Complication rate (adverse event greater than grade 2)

    Development of postoperative complications following rotator cuff reconstruction to treat massive tear

    Time frame: Up to two years postoperative

  2. Pain levels

    During clinical assessments, patient reported pain levels will be measured using visual analogue scale (VAS); scale 0 (low) to 15 (high)

    Time frame: Preoperative and postoperative (6 weeks, 3 months, 1- and 2-year follow-up visits)

  3. Healing rate

    Using radiological imaging (ultrasound), healing of the rotator cuff tear will be monitored over time

    Time frame: 6-week and 1-year exams (postoperative)

  4. Range of motion

    Clinical assessments of healing using the range of motion will be compared over time

    Time frame: Preoperative and postoperative (6 weeks, 3 months, 1- and 2-year follow-up visits)

07

Study locations

1 of 1 sites recruiting
  • Spital Thurgau AG
    Frauenfeld, Thurgau 8501, Switzerland
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06076902
Lead sponsor
Spital Thurgau AG
Responsible party
Sponsor
First posted
Oct 11, 2023
Start date
Apr 6, 2023
Primary completion
Apr 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Oct 11, 2023

Study contacts

Florian Hess, MD
Contact
florian.hess@stgag.ch
+41 58 144 8143
Florian Hess, MD
principal investigator · Spital Thurgau AG

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion